Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 442.00
Bid: 434.00
Ask: 442.50
Change: -2.00 (-0.45%)
Spread: 8.50 (1.959%)
Open: 443.00
High: 445.50
Low: 436.00
Prev. Close: 444.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

16 Jun 2020 08:18

RNS Number : 0917Q
J.P. Morgan Securities PLC.
16 June 2020
 

16 Jun 20

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

AIB Group plc

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

AIB Group plc

Guarantor (if any):

N/A

Aggregate nominal amount:

EUR bmk

Description:

Perpetual NC 5.5yr EUR Fixed Rate Reset AT1 notes

Listing: Euronext Dublin

Offer price:

TBC

Other offer terms:

Denoms: EUR 200,000 x EUR 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

BofA Securities (Stabilisation Manager(s))

Goldman Sachs International (Stabilisation Manager(s))

Goodbody (Stabilisation Manager(s))

NatWest Markets (Stabilisation Manager(s))

UBS Investment Bank (Stabilisation Manager(s))

Stabilisation period expected to start on:

16Jun20

Stabilisation period expected to end no later than:

16Jul20

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAEAXKKFFKEEEA
Date   Source Headline
14th Dec 20185:08 pmRNSDirectorate Change
2nd Nov 20185:32 pmRNSAIB EBA European Wide Stress Tests 2018
26th Oct 20187:02 amRNSTrading Statement
26th Oct 20187:00 amRNSDirectorate Change
19th Oct 20182:35 pmRNSAIB - Date for Q3 Trading Update
5th Sep 201812:45 pmRNSDirectorate Change
17th Aug 20184:24 pmRNSNOTIFICATION OF TRANSACTION BY PDMR
27th Jul 20187:00 amRNSHalf-year Report
18th Jul 201810:16 amRNSPost Stabilisation Notice - AIB
6th Jul 201812:02 pmRNSAIB_CBI Countercyclical Buffer Requirement
26th Jun 20189:31 amRNSPre Stab Notice - AIB EUR FXD 7y
31st May 20184:14 pmRNSAIB Group announces date for H1 Financial Results
17th May 20187:00 amRNSAIB - Sale of non performing loan portfolio
14th May 20187:00 amRNSAIB Group plc confirms MREL Requirement
25th Apr 20184:53 pmRNSResult of the Annual General Meeting
25th Apr 20187:00 amRNSAIB Q1 2018 Trading Statement
19th Apr 20184:52 pmRNSAIB statement on review of remuneration policy
18th Apr 20183:38 pmRNSAIB announces date for Trading Update
16th Apr 201812:39 pmRNSDirector/PDMR Shareholding
26th Mar 201810:02 amRNSPost Stabilisation Notice
22nd Mar 20181:20 pmRNSStabilisation Notice
22nd Mar 20187:00 amRNSNotice of AGM
1st Mar 20187:00 amRNSAnnual Financial Report
6th Feb 20189:22 amRNSRectification to previous PDMR Notification
14th Dec 20174:01 pmRNSDirectorate Change
13th Dec 201711:49 amRNSDirector/PDMR Shareholding
13th Dec 201711:02 amRNSCourt approval of the AIB reduction of capital
12th Dec 20174:39 pmRNSStandard Form TR-1
11th Dec 20177:02 amRNSAdmission to trading of AIB HoldCo Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.